Altogether, our studies suggest that E-Rspo2- and P-Rspo3-driven tumours are exquisitely sensitive to Porcn inhibitors in vivo, and that even in the presence of additional oncogenic insults, these cells remain dependent on WNT signalling for proliferative expansion. Here, PORCN is linked to neoplasm.